Diabetes drug 'could be used to end agony of transplant rejection'

Drugs currently used have a number of side effects, including leaving patients at greater risk of infections and cancer, because they are unable to specifically target the area of the immune system responsible for organ rejection. In breakthrough research funded by British Heart Foundation experts found the enzyme glucokinase increases the movement of a cells […]